| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.02 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |